Definitive Contract W58P0522C0014
Award Date 2/17/22
Potential Completion Date 9/9/22
Potential Value $52M
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Seattle, WA 98109, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded a $25.7 million cost-plus-fixed-fee delivery order to Inbios International Inc., a minority-owned biotechnology company headquartered in Seattle, Washington. The contract, issued on June 15, 2020, supports COVID-19 diagnostic development efforts through FDA Emergency Use Authorization antigen detection optimization and fast-track serology assay advancement. The work will be performed in Seattle and is scheduled for completion by May 31, 2025. This delivery order...
- This $806,303.37 cost-plus-fixed-fee delivery order contract was awarded by the Department of the Army Medical Command to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The contract is for other direct costs and does not have a set-aside designation. Inbios International specializes in the design, development, and manufacture of immunodiagnostic devices, and has received over $85 million in prime contract awards from agencies like...
- The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $1.35 billion definitive contract to Abbott Rapid DX North America LLC for COVID-19 antigen test kits. The contract calls for Abbott to provide over-the-counter COVID-19 antigen test kits for personnel use, as requested in a December 2021 special notice seeking information on the availability and sourcing of FDA Emergency Use Authorization or 510(k) cleared rapid antigen tests. Tests will be...
- The Department of State Bureau of East Asian and Pacific Affairs awarded a firm fixed-price purchase order to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington, for $143,218.00. The contract is for the supply of CDC 7553.0/ELISA detection kits, which are immunodiagnostic devices used for infectious disease testing. Inbios has a history of federal contract awards and grants related to the development and manufacture of diagnostic tests,...
- The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense (Department of Defense - Army - United States Army Acquisition Support Center) awarded Siemens Healthcare Diagnostics Inc., a division of Siemens Aktiengesellschaft (doing business as Siemens AG), a $595.94 million firm fixed price definitive contract to provide 50 million COVID-19 antigen test kits. The test kits will be delivered to Chambersburg, Pennsylvania between January 21, 2022 and June 25,...
- This federal contract award, valued at $4,708.00, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Inbios International Inc., a minority-owned biotechnology company based in Seattle, Washington. The contract is for the procurement of "TEST KIT,VISCERAL L" and has a completion date of June 24, 2024. Inbios International Inc. is a veteran-owned, for-profit organization that specializes in the design, development, and manufacture of immunodiagnostic...
- The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $1.8 billion firm fixed price definitive contract to Ihealth Labs Inc. to deliver COVID-19 antigen test kits. The contract supports the Rapid COVID-19 Antigen Test Kits solicitation issued by the Department of Defense and Department of Health and Human Services to assess availability of over-the-counter COVID-19 tests for use by government personnel. Ihealth Labs will provide COVID-19...
- <p>The Department of Defense (DOD), through the Department of the Army, awarded a $6.83 million firm fixed price definitive contract to Atlantic Trading LLC, doing business as Atlantic Trading, to provide COVID-19 Antigen Over-The-Counter (OTC) Test Kits. The place of performance will be Austin, Texas, and the period of performance is January 7, 2022 through January 21, 2022. No subcontractors were identified.</p>
- The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded Cepheid, a subsidiary of Danaher Corporation, a $4.9 million firm fixed price delivery order contract to provide COVID-19 testing support. The contract, awarded under the National Interest Action Code for Coronavirus and running from January 11, 2022 to March 4, 2022, will see Cepheid provide its polymerase chain reaction diagnostic tests and related equipment and services from its Place of...
- The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $5.9 million firm fixed price delivery order to Biofire Defense LLC. The order is for the purchase of COVID-19 assays, external control materials, and software module updates to support the agency's response to the Coronavirus pandemic. Performance will take place in Salt Lake City, Utah, through December 2020. No set aside designation or subcontractors were indicated. The funding agency...
The Department of the Army Acquisition Support Center Joint Program Executive Office for Chemical and Biological Defense (DOD - Army - USASC) awarded a $52 million firm fixed price definitive contract to Inbios International Inc. of Seattle, Washington to provide COVID-19 over-the-counter test kits. The contract runs from February 17, 2022 through September 9, 2022 to support the National Interest Action Code of Coronavirus COVID-19. No subcontractors were identified.
Generated 11/27/23, 6:54 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Other Administrative Action | $0 | 8/2/22 | |
| P00003 | Change Order | $0 | 6/30/22 | |
| P00002 | Change Order | $0 | 6/24/22 | |
| P00001 | Exercise an Option | ($1m) | 3/15/22 | |
| Not listed | Not listed | $53.5m | 2/17/22 |